EKSO (Ekso Bionics Holdings) Total Equity: $5.74 Mil (As of Mar. 2026)


EKSO Ekso Bionics Holdings Inc EKSO
32 GF Score
Price $11.65
GF Value $4.36
Valuation Significantly Overvalued
! 10 Warning Signs
View Full Analysis

What is Ekso Bionics Holdings Total Equity?

Ekso Bionics Holdings EKSO -0.42% 32 Total Equity is $5.74 Mil as of Mar. 2026. GuruFocus rates EKSO with a GF Score™ of 32/100 and a GF Value™ of $4.36 (Significantly Overvalued). The stock has 10 warning signs investors should review.

Ekso Bionics Holdings's total equity for the quarter that ended in Mar. 2026 was $5.74 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Ekso Bionics Holdings Total Equity Historical Data

* Premium members only.

The historical data trend for Ekso Bionics Holdings's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ekso Bionics Holdings Total Equity Chart

Ekso Bionics Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 37.22 25.44 12.61 12.71 9.03

Ekso Bionics Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.69 10.93 9.68 9.03 5.74
EKSO
32GF Score
Ekso Bionics Holdings Inc EKSO
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ekso Bionics Holdings Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Ekso Bionics Holdings's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=20.111-11.084
=9.03

Ekso Bionics Holdings's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=19.668-13.928
=5.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $5.74 Mil mean?
Ekso Bionics Holdings (EKSO) has a Total Equity of $5.74 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Ekso Bionics Holdings and its competitors.
Is Ekso Bionics Holdings' Total Equity too high?
Ekso Bionics Holdings' current Total Equity is $5.74 Mil. Overall, Ekso Bionics Holdings has a GF Score™ of 32/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ekso Bionics Holdings' Total Equity compare to POCI and HBIO?
Ekso Bionics Holdings' Total Equity of $5.74 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Ekso Bionics Holdings and its competitors. Ekso Bionics Holdings's current Total Equity is $5.74 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ekso Bionics Holdings stock overvalued right now?
Based on GuruFocus' analysis, Ekso Bionics Holdings (EKSO) is currently considered Significantly Overvalued. The stock's GF Value™ is $4.36, compared to a current price of $11.65 — trading 167.2% above its estimated fair value. The current Total Equity is $5.74 Mil. Ekso Bionics Holdings' overall GF Score™ is 32/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Ekso Bionics Holdings (EKSO), the current Total Equity is $5.74 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ekso Bionics Holdings (EKSO) Overvalued in 2026?

Based on GuruFocus' analysis, Ekso Bionics Holdings stock appears to be overvalued. The current stock price of $11.65 is trading 167.2% above its estimated GF Value™ of $4.36. GuruFocus considers Ekso Bionics Holdings to be Significantly Overvalued.

Key valuation signals for EKSO:

  • Total Equity: $5.74 Mil
  • GF Value™: $4.36 vs. price of $11.65 (167.2% above fair value)
  • GF Score™: 32/100 with 10 warning signs

No single metric tells the full story. See the EKSO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ekso Bionics Holdings Business Description

Address 101 Glacier Point, Suite A, San Rafael, CA, USA, 94901
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.
32GF Score

Get the complete analysis for EKSO

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.65
Price
$4.36
GF Value